Financiere de Tubize SA operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Financiere de Tubize SA with three other
pharmaceutical manufacturers in Europe:
Laboratorios Farmaceuticos Rovi S.A.
sales of 419.96 million Euros [US$491.76 million]
of which 78%
Eczacibasi Ilac Sanayi ve T.A.S.
(909.13 million Turkish Liras [US$102.61 million]
of which 84%
was Health), and
based in FRANCE
(110.32 million Euros [US$129.18 million]
of which 60%
was Commercialized Vaccines).
During the second
quarter of 2021, sales at Financiere de Tubize SA totalled
205.97 million Euro.
an increase of 57.6%
from the 130.66 million Euro in sales at the company during the second quarter of 2020.
Financiere de Tubize SA reported sales of 263.87 million Euro (US$308.98 million)
December of 2020.
decrease of 7.8%
versus 2019, when the company's sales were 286.08 million Euro.